All Outputs (7)

Quality prescribing for Benzodiazepines and z-drugs: guide for improvement 2024 to 2027 (2024)
Report
Cook, A., Mair, A., Smith, G., & Strath, A. (2024). Quality prescribing for Benzodiazepines and z-drugs: guide for improvement 2024 to 2027

Benzodiazepines and z-drugs are indicated for a variety of conditions including the short-term relief of severe insomnia and some anxiety disorders. People can quickly become tolerant to the therapeutic effects of benzodiazepines and z-drugs, renderi... Read More about Quality prescribing for Benzodiazepines and z-drugs: guide for improvement 2024 to 2027.

Polypharmacy and Deprescribing (2024)
Book Chapter
Mair, A. R., Jordon, M., & Mullan, J. (2024). Polypharmacy and Deprescribing. In J. Jose, A. R. Cox, & V. Paudyal (Eds.), Principles and Practice of Pharmacovigilance and Drug Safety (405-435). Springer. https://doi.org/10.1007/978-3-031-51089-2_18

Polypharmacy contributes to medication-related harm. Medication-related harm accounts for approximately 9% of hospital admissions worldwide, and it is estimated that many of these hospitalisations are preventable. It is therefore important to conside... Read More about Polypharmacy and Deprescribing.

Safe Prescribing and Monitoring in the Older Person (2024)
Book Chapter
Mair, A. R., Mair, A. R., Hilmer, S., & Kouladjian O’Donnell, L. (2024). Safe Prescribing and Monitoring in the Older Person. In J. Jose, A. R. Cox, & V. Paudyal (Eds.), Principles and Practice of Pharmacovigilance and Drug Safety (459-482). Springer. https://doi.org/10.1007/978-3-031-51089-2_20

This chapter will consider the main factors that increase the risk of adverse drug reactions and events in older people. This will include changes in physiology that affect the older person. It will also outline how older people should be prioritized... Read More about Safe Prescribing and Monitoring in the Older Person.

Quality prescribing for antidepressants: guide for improvement 2024 to 2027 (2024)
Report
Cook, A., Mair, A., Smith, G., & Strath, A. (2024). Quality prescribing for antidepressants: guide for improvement 2024 to 2027

The prescribing of antidepressants continues to increase in Scotland, with many people receiving antidepressants for two years or more. This may be appropriate for some individuals, but it is important that ongoing treatment is reviewed regularly and... Read More about Quality prescribing for antidepressants: guide for improvement 2024 to 2027.

Quality Prescribing Strategy for Respiratory: A Guide for Improvement 2024-2027 (2024)
Report
Anderson, D., Fardon, T., Mair, A., Korsah, P., Smith, G., Strath, A., McMahon, A., & Leitch, J. (2024). Quality Prescribing Strategy for Respiratory: A Guide for Improvement 2024-2027

Medication without harm: policy brief (2024)
Report
Galappatthy, P., Mair, A., & Dhingra-Kumar, N. (2024). Medication without harm: policy brief. Geneva: World Health Organization

Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027 (2024)
Report
Mair, A., Kennon, B., Chalmers, J., Smith, G., Strath, A., McMahon, A., & Leitch, J. (2024). Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027. Scottish Government

This quality prescribing guide is intended to support clinicians across the multidisciplinary team and people with Type 2 Diabetes Mellitus (T2DM) in shared decision-making and the effective use of medicines, and offers practical advice and options f... Read More about Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027.